Quantitating immunosuppression: Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice

Transplantation

Volumn 61, Issue 11, 1996, Pages 1618-1624

  Batiuk, Thomas D ^a   Urmson, Joan ^a   Vincent, Dianne ^a   Yatscoff, Randall W ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCINEURIN; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; PHOSPHATASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INDUCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MOUSE; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; CALCINEURIN; CALMODULIN-BINDING PROTEINS; CYCLOSPORINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEIN PHOSPHATASE; RNA, MESSENGER; SPLEEN;

EID: 0029952570     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606150-00012     Document Type: Article

References (35)

1. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin, a specific cytosolic binding protein for cyclosporine A. Science 1984; 226: 544.
2. Thériault Y, Logan TM, Meadows R, et al. Solution structure of the cyclosporine A/cyclophilin complex by NMR. Nature 1993; 361: 88.
3. p is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993; 365: 352.
4. Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR. Cyclosporine A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989; 246: 1617.
5. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13: 136.
6. Ullman DS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990; 8: 421.
7. McCaffrey PG, Luo C, Kerppola TK, et al. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 1993; 262: 750.
8. Borel JF. Pharmacology of cyclosporine (Sandimmune) IV. Pharmacological properties in vivo. Pharmcol Rev 1989; 41: 260.
9. Batiuk TD, Pazderka F, Halloran PF. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995; 59: 1400.
10. Pai SY, Fruman DA, Leong T, et al. Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A. Blood 1994; 84: 3974.
11. Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression. Evidence that IFN-τ induces its own expression in remote sites. J Immunol 1992; 148: 3837.
12. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF. Regulation of MHC in vivo: bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell independent, cyclosporine sensitive mechanism. J Immunol 1988; 141: 792.
13. Copeland KR, Yatscoff RW, McKenna R. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance. Clin Chem 1990; 36: 225.
14. Batiuk TD, Pazderka F, Enns J, Halloran PF. Quantitating cyclosporine (CsA) immunosuppression: comparing calcineurin inhibition by two oral formulations [Abstract]. J Am Soc Nephrol 1995; 6: 1072.
15. Autenried P, Halloran PF. Cyclosporine blocks the induction of class I and class II MHC products in mouse kidney by graft-vs-host disease. J Immunol 1985; 135: 3922.
16. Halloran PF, Urmson J, Farkas S, van der Meide P, Autenried P. Regulation of MHC expression in vivo. IFN-α/β inducers and recombinant IFN-α modulate MHC antigen expression in mouse tissues. J Immunol 1989; 142: 4241.
17. Halloran PF, Urmson J, Farkas S, et al. Effects of cyclosporine on systemic MHC expression. Evidence that non T cells produce gamma interferon in vivo and are inhabitable by cyclosporine A. Transplantation 1988; 46: 68S.
18. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-1pr/1pr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988; 141: 2303.
19. Cockfield SM, Ramassar V, Urmson J, Halloran PF. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-τ. J Immunol 1989; 142: 1120.
20. Sims TN, Vincent D, Urmson J, Halloran PF. MHC regulation in non-lymphoid tissues of IFN-γ gene knockout (GKO) mice: evidence for a unique role for IFN-γ in MHC induction [Abstract]. FASEB J 1995; 9: A491.
21. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982.
22. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992; 89: 3686.
23. Miyagawa S, Stepkowski SM, Lawen JG, Rutzky LP, Kahan BD. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences. Transplantation 1991; 52: 851.
24. Koutouby R, Zucker C, Zucker K, et al. Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction. Hum Immunol 1993; 36: 227.
25. Chatenoud L, Ferran C, Bach JF. The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. Curr Top Microbiol Immunol 1991; 174: 121.
26. Noronha IL, Eberlein-Gonska M, Hartley B, Stephens S, Cameron JS, Waldherr R. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies. Transplantation 1992; 54: 1017.
27. Khanna A, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor-beta dependent mechanism of inhibition of cell growth [Abstract]. Proceedings of the ASTP 12th annual meeting, 1993: 92.
28. Kupiec-Weglinski JW, Filho MA, Strom TB, Tilney NL. Sparing of suppressor cells: a critical action of cyclosporine. Transplantation 1984; 38: 97.
29. Klaus GGB, Chisholm PM. Does cyclosporine act in vivo as it does in vitro? Immunol Today 1986; 7: 101.
30. Klaus GGB, Dongworth DW. Effect of cyclosporin A on B cell functions in the mouse. In: White DJG, ed. Cyclosporin A. Amsterdam: Elsevier Biomed Press, 1982: 233.
31. Kasiske BL, Awni WM, Heim-Duthoy KL, et al. Alterations in cyclosporine pharmacokinetics after renal transplantation are linked to rapid increases in hematocrit, lipoproteins, and serum protein. Transplant Proc 1988; 20: 485.
32. Hughes TA, Gaber AO, Montgomery CE. Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins. Ther Drug Monit 1991; 13: 289.
33. Lemaire M, Tillement JP. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol 1982; 34: 715.
34. Batiuk TD, Pazderka F, Enns J, De Castro L, Halloran PF. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation 1996; 61(1): 158.
35. Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. N Engl J Med 1986; 314: 1219.